Feb 18 Moderna says FDA will now consider its new mRNA flu shot after initial refusal By Lauran Neergaard, Associated Press Moderna announced the change Wednesday, about a week after revealing that the FDA’s vaccine chief was refusing to review the new vaccine, made with Nobel Prize-winning mRNA technology. Continue reading
Jan 18 FDA's new expedited drug program raises legal questions and concerns By Matthew Perrone, Associated Press The FDA commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the agency. Continue reading
Jan 11 Watch 5:15 Investigation raises concerns about lack of FDA quality testing for generic drugs By John Yang, Andrew Corkery By some estimates, about 90% of prescriptions in the U.S. are filled with generic drugs. The Food and Drug Administration says that all agency-approved generic drugs “have the same high quality” as brand-name drugs, but a ProPublica investigation found that… Continue watching
Nov 23 What to know about menopause hormone therapy after FDA removed 'black box' warnings By Grace Abels, PolitiFact The FDA removed safety warnings from several hormone drugs used to treat menopause symptoms. Here’s what you need to know about these treatments before your next doctor's appointment. Continue reading
Nov 19 What are biologics and can the Trump administration make them cheaper with biosimilars? By Madison Czopek, PolitiFact Biologics represented 5% of the drugs prescribed in the U.S. in 2024, but they accounted for more than half of the country’s total prescription medicine spending, according to health data analysis company IQVIA. The Trump administration said it hopes to… Continue reading
Nov 10 WATCH: RFK Jr. says FDA will remove long-standing warning from hormone-based menopause drugs By Matthew Perrone, Associated Press The change announced Monday is a break from more than 20 years of FDA policy, in which the drugs carried the agency's most severe warning label. Continue reading
Nov 09 What to know about the FDA's recall of the blood pressure drug prazosin By C. Michael White, The Conversation A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug Administration because it contains elevated levels of cancer-causing chemicals called nitrosamines. Continue reading
Oct 29 WATCH: Health Secretary RFK Jr. announces new FDA move to fast-track biosimilar drug approvals By Tom Murphy, Matthew Perrone, Associated Press Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers. Continue reading
Oct 03 WATCH: FDA and HHS not endorsing generic abortion pill they just approved, White House says By Associated Press The White House said Friday that the Food and Drug Administration’s approval of a generic form of mifepristone was just following the law and not a sign of support for the abortion pill. Continue reading
Oct 02 FDA approves another generic abortion pill, prompting conservative backlash By Matthew Perrone, Associated Press Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration. Continue reading